2016-17

  1. Saour B, Stahura H, Rau E, Tan H, Torosoff M, Steckman D. Beware isoproterenol in unknown RV cardiomyopathies. HRS 2016

  2. Stahura H, Saour B, Philbin E, Torosoff M, Steckman D.  Life-Saving Fascicular Ventricular Tachycardia Ablation HRS 2016. 

  3. Peiper J, Ashamalla M, Sedhom D, Yager N, Torosoff M. The Obesity Paradox Decoded: BMI Affects Co-Morbidities but not Outcomes in Ischemic Stroke IAC WCHD 2016.

  4. Ashamalla M, Peiper J, Sedhom D, Yager N, Torosoff M. Effects of Gender and BMI on Comorbidities in Patients with Non-Hemorrhagic Stroke AHA ATVB 2016.

  5. Fahad F, Belov D, Philbin E, Torosoff M. Lack of Post LVAD Implantation Weight Loss is Associated with Volume Overload During Intermediate Follow Up IAC WCHD 2016, accepted.

  6. Radmila Lyubarova, Santica Marcovina, Jerome Fleg, Patrice Desvigne Nickens, Alexandru Topliceanu, Yao Yao, Ruth McBride, William Boden. Effects of Extended-release Niacin on Lipoprotein-associated Phospholipase A2 Levels and Clinical Outcomes in Patients with Established Cardiovascular Disease and Low Levels of Baseline HDL-cholesterol: Post Hoc Analysis of the AIM HIGH Trial. J Am Coll Cardiol. 2016;67(13_S):2080. (Moderated poster presented at ACC meeting.)

  7. Rau E, Saour B, Tan H, Steckman D. Cryptogenic asystole. (Accepted HRS Abstract 2016).

  8. K. Drzymalski, S. Mookherjee, R. Lyubarova. Electronically silent total coronary occlusion in a young Southeast Asian man with very low HDL and elevated tryglycerides. Submitted to ACC 2017.

  9. K. Drzymalski, A. Nappi. Bridging with Tirofiban after loading dose of P2Y12 receptor inhibitor during Percutaneous Coronary Intervention (PCI) in Acute Coronary Syndrome (ACS).

  10. K. Drzymalski, M. Sidhu, W. Boden. Effect of periprocedural myocardial infarction on long-term outcomes in patients undergoing percutaneous coronary intervention for stable ischemic heart disease (A-Post-HOC Analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial.

  11. K. Drzymalski, A. Nappi. Ischemia-CKD Trial (Sub-Investigator).  Quality Improvement: Troponin elevation associated with septic shock, not an indicator of obstructive coronary artery disease in septic shock survivors.

  12. R. Garcia, R. Lyubarova.  Noninvasive Assessment of the Effects of Pulmonary Hypertension has on Renal Transplant Outcomes.

  13. R. Garcia, M. Scheidler.  Gender Differences in the Ambulatory Treatment of Hypertension in Patients with Heart Failure.  Housestaff Research Day; Albany Medical College; April 2016

  14. R. Garcia, E. Philbin, M. Torosoff, M. Scheidler.  Gender Differences in the Ambulatory Treatment of Hypertension in Patients with Heart Failure.    Quality of Care & Outcomes Research (QCOR) in Cardiovascular Disease and Stroke; Phoenix, AZ; February 2016.

  15. Y. Piatetsky, R. Garcia, M. Torosoff, M. Scheidler.  Attainment of Optimal Blood Pressure in Ambulatory Heart Failure Patients submitted to AHA QCOR.16) Aortic Valve Area (AVA) in Patients with Sever Aortic Stenosis Undergoing Trans-Catheter Aortic Valve Replacement; 2016 AHA Scientific Sessions Conference.

  16. Incidence of Pericardial Effusion Based on Echocardiography Criteria in Renal Transplant Patients on Chronic Immunosuppressive Therapy.  Quality Improvement: Syncope Protocol.

  17. Aspirin induced Eosinophilia-Associated Coronary Artery Vasospasm presenting as Takotsubo Cardiomyopathy.  ACC, Washington, DC, March 2017.

  18. H. Patel, J. Schulman-Marcus, co-investigator, R Lyubarova, PI.  Trends in dual antiplatelet use in medically managed patients with non-ST elevation myocardial infarctions from the NCDR ACTION Registry-GWTG.

  19. S. Purga, R. Lyubarova, D. Steckman.  The Brugada Syndrome Mimicking an Acute ST-Elevation Myocardial Infarction. ACC, Washington, DC, March 2017.

  20. Rau EM, Koutroumpakis E, Schwartz B, Espey J, Dumas C, Fantauzzi J, Torosoff M, Steckman D. Characteristics of Echocardiography and Computed Tomography in Detecting Coronary and Aortic Atherosclerosis in Patients Referred for Atrial Fibrillation Ablation. Will be a poster presentation at ASE Scientific Sessions 2017 June 2-6 Baltimore.

  21. Koutroumpakis E, Schwartz B, Espey J, Rau EM, Steckman D, Torosoff M. Echocardiographic Evidence of Systemic Atherosclerosis in Patients Referred for Atrial Fibrillation Ablation. Poster presentation at QCOR 2017 Scientific Sessions. 

  22. Rau EM and El-Hajjar M. Aortic Valvuloplasty via the Radial Artery: Case Reports and Review of the literature. Catheter Cardiovasc Interv 2017 March 17 (epub ahead of print).

  23. Rau EM, Saour B, Tan H, Steckman D. Cryptogenic Asystole. Poster presented at: Heart Rhythm 2016 37th Annual Scientific Sessions; 2016 May 4-7; San Francisco, CA. 

  24. Patient Awareness of Atrial Fibrillation and Ablation Therapy.  Project investigating patient knowledge and understanding of atrial fibrillation and treatment options (PI: D. Steckman).

  25. Participate in Mission Life Line Project as committee member; attending meetings, review case fails and participate in education related to improving our STEMI first medical contact to device times.

  26. Y. Piatetsky, R. Garcia, M. Torosoff, M. Scheidler.  Attainment of Optimal Blood Pressure in Ambulatory Heart Failure Patients submitted to AHA QCOR.28) R. Garcia, M. Scheidler.  Gender Differences in the Ambulatory Treatment of Hypertension in Patients with Heart Failure.

  27. Cardiac Implantable Electronic Device Magnetic Resonance Imaging Registry (CIED-MRI Registry) - Currently under IRB Approval.

  28. Stahura, D. Steckman. A Masquerading Target Rash after Pacemaker Implantation. Submitted to HRS. 31) H. Stahura, D. Steckman. Lifesaving Fasicular VT Ablation Submitted to HRS.

  29. H. Patel, H. Stahura, M. Torosoff, A. Akujuo, R. Lyubarova.  Embolic Stroke and Pericardial Effusion as an Initial Manifestation of Blood Culture Negative Native-Valve Endocarditis with Abscess; Tissue Contaminant or a Highly Virulent Propionibacterium Acnes Infection? accepted by ACC.

  30. H. Stahura, R. Lyubarova. Achievement of guideline directed medical therapy in patients with stable ischemic heart disease with and without chronic kidney disease.

  31. Improved Hospital Outcomes with Hypokalemia on Admission in Cardiac Arrest Survivors Treated with Therapeutic Hypothermia.

  32. Left Ventricular Outflow Tract Size Correlation with Implanted Transcatheter Aortic Valve Size and Impact on the Rate of Pacemaker Implantation.

  33. R. Lyubarova, S. Marcovina, J. Felg, A. Topliceanu. Effects of Extended-Release Niacin on Lipoprotein-Associated Phospholipase A2 Levels and Clinical Outcomes in Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial. ACC:  J Am Coll Cardiol. 206;67(13_S):2080. Doi: 10.1016/S0735-1097(16)32081-2. 

  34. A. Toplieanu, N. Yager, E. Maceira, M. Torosoff. Bivalirudin Fails to Prevent Atrial Thombus Development in Patient with Atrial Fibrillation with Heparin Induced Thrombocytopenia and Thrombosis Syndrome submitted to BMJ.

Previous
Previous

2017-18

Next
Next

2015-16